Krensavage Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Krensavage Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-891,026	Closed	-$4.63M	–	16
2016 Q4	$4.63M	Buy	891,026 +7,026	+0.8%	+$33K	1.66%	13
2016 Q3	$4.13M	Sell	884,000 -26,703	-3%	-$125K	1.49%	15
2016 Q2	$3.59M	Buy	910,703 +4,657	+0.5%	+$17.4K	1.29%	18
2016 Q1	$2.81M	Buy	906,046 +4,212	+0.5%	+$14.1K	1.01%	19
2015 Q4	$4.12M	Buy	+901,834	New	+$4.28M	1.31%	19

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Krensavage Asset Management's DSCI Position: Q1 2017 in Review

Krensavage Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 891,026 shares — an estimated $4.63M sold.

Krensavage Asset Management first reported a position in DSCI in Q4 2015 and held it in 5 quarters. The position peaked at $4.63M in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Krensavage Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Krensavage Asset Management sold 891,026 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $4.63M.
Krensavage Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 5 quarters.
Krensavage Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $4.63M in Q4 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Krensavage Asset Management's 13F filing for Q1 2017, filed 15 May 2017.